APPLICATION
ANDA091164
TYPE
ANDA
ORIGINAL APPROVAL
2010-06-28
LATEST ACTION
2025-02-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
ANASTROZOLEPrescription
ANASTROZOLE 1MG · TABLET · ORAL
Approval history
2025-02-18Labeling · Supplement 3 · standardAP
2019-10-09Labeling · Supplement 2 · standardAP
2016-10-22Labeling · Supplement 1 · standardAP
2010-06-28OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.